Autres langues Bio-Techne Corporation

Actions

TECH

US09073M1045

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
64,06 ^USD	+2,23%		+3,12%	-16,98%

26/04	Bio-Techne Corporation et Novomol-Dx annoncent un test de biomarqueurs oculaires au point de service	CI
18/04	BIO-TECHNE CORPORATION : Deutsche Bank Securities est neutre	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY	26/04
Bio-Techne Corporation and Novomol-Dx Announce Point-of-Care Ocular Biomarker Assay	26/04
Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe	23/04
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS	23/04
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS	10/04
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY	08/04
BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS	01/04
Bio-Techne Positioned for Growth Amid Biotech Funding Recovery, UBS Says	28/03
BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES	28/03
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA	25/03
Bio-Techne Says European Union IVDR Certification Received for Diagnostic Test Tracking Chronic Myeloid Leukemia	22/03
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA	22/03
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES AND MEDTECH INVESTOR FORUM	13/03
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM	12/03
BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE	06/03
North American Morning Briefing : Hopes of March -2-	05/02
Bio-Techne Seeks M&A	01/02
Bio-Techne's Fiscal Q2 Adjusted Earnings Fall, Net Sales Rise	01/02
Earnings Flash (TECH) BIO-TECHNE CORPORATION Reports Q2 Revenue $272.6M, vs. Street Est of $277.7M	01/02
BIO-TECHNE DECLARES DIVIDEND	01/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Bio-Techne Corporation

Actions

TECH

US09073M1045

Autres langues

Filtres